Aging, Emerging Markets And Precision Medicine Will Unlock Secular Growth
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
27 Jul 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
UK£174.51
31.4% undervalued intrinsic discount21 Aug
UK£119.68
1Y
-8.5%7D
2.0%1Y
-8.5%7D
2.0%